Zydus Lifesciences gets FDA final approval for Olanzapine tablets

TAGS

Zydus Lifesciences said that it has secured final approval for Olanzapine Orally Disintegrating Tablets USP, 5 mg, 10mg, 15 mg, and 20 mg from the Food and Drug Administration (FDA).

The approval gives the Indian pharma company to manufacture and market the generic version of Zyprexa Zydis Orally Disintegrating Tablets.

See also  Tata Steel commissions 0.5MTPA steel recycling plant in Rohtak

Olanzapine Orally Disintegrating Tablets USP, 5 mg, 10 mg, 15 mg, and 20 mg are indicated for the treatment of some mental/mood conditions like bipolar disorder and .

They could also be used in combination with other medications for the treatment of .

Zydus Lifesciences gets FDA final approval for Olanzapine tablets

Zydus Lifesciences gets FDA final approval for Olanzapine tablets. Photo courtesy of Zydus Cadila.

Olanzapine tablets belong to the atypical antipsychotics class of drugs and function by helping in the restoration of the balance of some natural substances in the brain.

See also  Revolutionary change in Bangladesh: Muhammad Yunus takes charge after historic uprising

Zydus Lifesciences will manufacture the drug at its formulation manufacturing plant in Moraiya, Ahmedabad, .

As per IQVIA MAT December 2022, the estimated annual sales of Olanzapine Orally Disintegrating Tablets USP, 5 mg, 10 mg, 15 mg, and 20 mg in the US are $28.3 million.


Discover more from Business-News-Today.com

Subscribe to get the latest posts sent to your email.

CATEGORIES
TAGS
Share This